Table 1. Characteristics of subjects with ESRD.
Patient Characteristics | Plasma Markers | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Gender | Age (Years) | Etiology | Time on Dialysis (Months | 24 Hour Urine Output (Ounces) | Pre-D Cr1 (mg/ml) | Pre-D BUN (mg/dl) | Post-D BUN (mg/dl) | Pre-D IS2 (μg/ml) | Post-D IS (μg/ml) | |
Residual Renal Function | 1 | M | 47 | DM3 | 36 | 12–18 | 9.38 | 63 | 20 | 70.21 | 44.14 |
2 | M | 70 | DM | 108 | 18–24 | 6.1 | 55 | 14 | 42.67 | 26.7 | |
3 | F | 64 | DM | 3 | 18 | 4.45 | 42 | 7 | 12.32 | 5.71 | |
4 | M | 59 | DM | 60 | 12 | 4.27 | 38 | 11 | 28.55 | 18.63 | |
5 | M | 42 | DM | 7 | 9 | 7.25 | 63 | 21 | 28.33 | 19.41 | |
No Residual Renal Function | 6 | M | 28 | Transplant Rejection | 36 | 0 | 13.28 | 47 | 12 | 79.56 | 40.2 |
7 | M | 39 | FSGS4 | 36 | 1 | 16.86 | 71 | 19 | 46.49 | 34.15 | |
8 | M | 53 | DM | 84 | 1 | 7.98 | 63 | 15 | 65.09 | 44.29 | |
9 | F | 32 | DM | 48 | 0 | 7.6 | 45 | 10 | 68.56 | 30.23 | |
10 | M | 50 | HTN5 | 180 | 0 | 8.58 | 73 | 18 | 27.89 | 13.07 |
The preponderance of patients with diabetic glomerulosclerosis reflects the exclusion of patients with active glomerulonephritis or other inflammatory processes and the predominance of diabetic glomeruosclerosis in our dialysis population. Abbreviations: 1 = Creatinine, 2 = indoxyl sulfate, 3 = diabetes mellitus, 4 = focal segmental glomerulosclerosis, 5 = hypertensive nephropathy.